News
Adverse reactions occurring in patients with MSI-H or dMMR endometrial carcinoma ... for the treatment of patients with FIGO 2014 Stage III-IVA cervical cancer. KEYTRUDA, in combination with ...
They analyzed data from June 2019 to August 2023, including all individuals with apparent early-stage (FIGO [International Federation of Gynecology & Obstetrics] 2009 stage I or II) endometrial cancer ...
ABSTRACT: Uterine carcinosarcoma, also known as malignant mixed Müllerian ... In the case presented, a patient initially diagnosed with FIGO stage II high-grade serous carcinoma was reclassified as ...
The pathological results and staging status were recorded based on the FIGO (International Federation of Gynecology and Obstetrics) staging system: the 2018 edition for cervical cancer, the 2009 ...
Participants meeting specific inclusion and exclusion criteria were enrolled as follows: The control group (n=29) including uterine fibroids or endometrioma ... and 16 diagnosed with ovarian cancer ...
KEYTRUDA, in combination with chemoradiotherapy (CRT), is indicated for the treatment of patients with FIGO 2014 Stage III-IVA cervical cancer. KEYTRUDA ... patients with primary advanced or recurrent ...
Endometrial cancer is the most common gynecological cancer in highly-developed countries, most often affecting women after ...
The following is a summary of “Do MRI structured reports with FIGO classifications of leiomyomas contain adequate information ...
Fleming, MD: Thank you so much. I'm delighted to have been invited. As you know, talking about endometrial cancer is one of my favorite things. Matulonis: As I mentioned, you are truly a pioneer ...
That single decision to call her doctor may have saved her life. Uterine cancer remains one of the most prevalent yet underdiscussed health threats affecting individuals with female reproductive ...
Researchers from the University of Missouri School of Medicine have shed new light on how the uterus develops, leading to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results